Eldelumab - CAS 946414-98-8

Eldelumab (BMS-936557) is a humanized anti-IP-10 IgG type 1 monoclonal antibody with inhibitory activity against CXCL10. It has anti-inflammatory properties, selectively binds to CXCL10, and can be used in the study of rheumatoid arthritis, ulcerative colitis, and Crohn's disease.

CXCR

Immunology/Inflammation, GPCR/G Protein, Autophagy

946308

0.973

-20°C

Ice Packs

Inhibitory Antibodies